Neglecting to test at the rectal site would miss up to 20% of infections in high-risk women.
Cervical testing for gonorrhea and chlamydia is regularly recommended for women younger than 25 as well as older high-risk women. However, most clinicians do not routinely test the rectum. To investigate whether this lapse leads to missed infections, investigators analyzed sexually transmitted disease (STD) surveillance data collected at public STD clinics from 2015 through 2016, focusing on the 3743 women (7.4%) who reported having anal intercourse within the last 3 months.
Of women tested at cervical and rectal sites, 4.5% were positive for gonorrhea and 10.4% for chlamydia. Among women with gonorrhea, 74 were positive at both sites, 31 at the genital site only, and 23 at the rectal site only. Among those with chlamydia, 171 were positive …
Reviewing Author
DisclosuresConsultant/Advisory BoardAicuris; Bayer; GSK; Innovative Molecules; Merck; MAPP Biopharmaceutical (Safety Monitoring Committee)
RoyaltiesUpToDate
Grant/Research SupportNIH/National Institute of Allergy and Infectious Diseases; GSK; Moderna; Assembly Biomedical; Aicuris
Editorial BoardsSexually Transmitted Diseases; Sexually Transmitted Infections; Journal of Infectious Diseases
Leadership PositionsID Division Chiefs Community of Practice (At-Large Member)
DisclosuresConsultant/Advisory BoardAicuris; Bayer; GSK; Innovative Molecules; Merck; MAPP Biopharmaceutical (Safety Monitoring Committee)
RoyaltiesUpToDate
Grant/Research SupportNIH/National Institute of Allergy and Infectious Diseases; GSK; Moderna; Assembly Biomedical; Aicuris
Editorial BoardsSexually Transmitted Diseases; Sexually Transmitted Infections; Journal of Infectious Diseases
Leadership PositionsID Division Chiefs Community of Practice (At-Large Member)